Stock Research for CLDX

CLDX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CLDX Stock Chart & Research Data

The CLDX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CLDX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CLDX Due diligence Resources & Stock Charts

The CLDX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CLDX Detailed Price Forecast - CNN Money CNN View CLDX Detailed Summary - Google Finance
Yahoo View CLDX Detailed Summary - Yahoo! Finance Zacks View CLDX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CLDX Trends & Analysis - Trade-Ideas Barrons View CLDX Major Holders - Barrons
NASDAQ View CLDX Call Transcripts - NASDAQ Seeking View CLDX Breaking News & Analysis - Seeking Alpha
Spotlight View CLDX Annual Report - CompanySpotlight.com OTC Report View CLDX OTC Short Report - OTCShortReport.com
TradeKing View CLDX Fundamentals - TradeKing Charts View CLDX SEC Filings - Bar Chart
WSJ View Historical Prices for CLDX - The WSJ Morningstar View Performance/Total Return for CLDX - Morningstar
MarketWatch View the Analyst Estimates for CLDX - MarketWatch CNBC View the Earnings History for CLDX - CNBC
StockMarketWatch View the CLDX Earnings - StockMarketWatch MacroAxis View CLDX Buy or Sell Recommendations - MacroAxis
Bullish View the CLDX Bullish Patterns - American Bulls Short Pains View CLDX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CLDX Stock Mentions - StockTwits PennyStocks View CLDX Stock Mentions - PennyStockTweets
Twitter View CLDX Stock Mentions - Twitter Invest Hub View CLDX Investment Forum News - Investor Hub
Yahoo View CLDX Stock Mentions - Yahoo! Message Board Seeking Alpha View CLDX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CLDX - SECform4.com Insider Cow View Insider Transactions for CLDX - Insider Cow
CNBC View CLDX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CLDX - OTC Markets
Yahoo View Insider Transactions for CLDX - Yahoo! Finance NASDAQ View Institutional Holdings for CLDX - NASDAQ


Stock Charts

FinViz View CLDX Stock Insight & Charts - FinViz.com StockCharts View CLDX Investment Charts - StockCharts.com
BarChart View CLDX Stock Overview & Charts - BarChart Trading View View CLDX User Generated Charts - Trading View




Latest Financial News for CLDX


Does Celldex (CLDX) Have the Potential to Rally 71.82% as Wall Street Analysts Expect?
Posted on Wednesday March 20, 2024

The consensus price target hints at a 71.8% upside potential for Celldex (CLDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.


Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Posted on Friday March 08, 2024

HAMPTON, N.J., March 08, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Leerink Partners Global Biopharma Conference on Monday, March 11, 2024 at 10:00 a.m. ET. A webcast of the presentation will be available on the "Events & Presentations” page of the "Investors & Media” section of the Celldex website. A replay will be available for 30 days following the event. About Celldex Therapeutics, Inc.Celldex i


Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
Posted on Tuesday March 05, 2024

HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony S. Marucci, President and Chief Executive Officer will participate in an “Inflammation & Immunology Corporate Panel Discussion” at TD Cowen’s 44th Annual Health Care Conference. The panel will be held on Tuesday, March 5, 2024 from 2:10 to 3:10 PM ET. A live webcast of the panel discussion will be available on the investor section of the Celldex website. A replay of the webcast


Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Posted on Tuesday March 05, 2024

HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public offering of 9,798,000 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase an additional 1,278,000 shares of common stock at a public offering price of $47.00 per share. All of the shares sold in the offering were sold by Celldex. The gross pro


Stock Market & Investing Books

Enter a stock symbol to view the stock details.